Blood transcriptome based biomarkers for human circadian phase

Diagnosis and treatment of circadian rhythm sleep-wake disorders both require assessment of circadian phase of the brain’s circadian pacemaker. The gold-standard univariate method is based on collection of a 24-hr time series of plasma melatonin, a suprachiasmatic nucleus-driven pineal hormone. We d...

Full description

Bibliographic Details
Main Authors: Emma E Laing, Carla S Möller-Levet, Norman Poh, Nayantara Santhi, Simon N Archer, Derk-Jan Dijk
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2017-02-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/20214
_version_ 1828168919303585792
author Emma E Laing
Carla S Möller-Levet
Norman Poh
Nayantara Santhi
Simon N Archer
Derk-Jan Dijk
author_facet Emma E Laing
Carla S Möller-Levet
Norman Poh
Nayantara Santhi
Simon N Archer
Derk-Jan Dijk
author_sort Emma E Laing
collection DOAJ
description Diagnosis and treatment of circadian rhythm sleep-wake disorders both require assessment of circadian phase of the brain’s circadian pacemaker. The gold-standard univariate method is based on collection of a 24-hr time series of plasma melatonin, a suprachiasmatic nucleus-driven pineal hormone. We developed and validated a multivariate whole-blood mRNA-based predictor of melatonin phase which requires few samples. Transcriptome data were collected under normal, sleep-deprivation and abnormal sleep-timing conditions to assess robustness of the predictor. Partial least square regression (PLSR), applied to the transcriptome, identified a set of 100 biomarkers primarily related to glucocorticoid signaling and immune function. Validation showed that PLSR-based predictors outperform published blood-derived circadian phase predictors. When given one sample as input, the R2 of predicted vs observed phase was 0.74, whereas for two samples taken 12 hr apart, R2 was 0.90. This blood transcriptome-based model enables assessment of circadian phase from a few samples.
first_indexed 2024-04-12T02:42:43Z
format Article
id doaj.art-1faf2ce4b4fe4419a4c48b1fdb79f13f
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T02:42:43Z
publishDate 2017-02-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-1faf2ce4b4fe4419a4c48b1fdb79f13f2022-12-22T03:51:16ZengeLife Sciences Publications LtdeLife2050-084X2017-02-01610.7554/eLife.20214Blood transcriptome based biomarkers for human circadian phaseEmma E Laing0https://orcid.org/0000-0002-2095-2442Carla S Möller-Levet1Norman Poh2Nayantara Santhi3Simon N Archer4Derk-Jan Dijk5Department of Microbial Sciences, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United KingdomBioinformatics Core Facility, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United KingdomDepartment of Computer Science, Faculty of Engineering and Physical Sciences, University of Surrey, Guildford, United KingdomSurrey Sleep Research Centre, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United KingdomSurrey Sleep Research Centre, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United KingdomSurrey Sleep Research Centre, School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United KingdomDiagnosis and treatment of circadian rhythm sleep-wake disorders both require assessment of circadian phase of the brain’s circadian pacemaker. The gold-standard univariate method is based on collection of a 24-hr time series of plasma melatonin, a suprachiasmatic nucleus-driven pineal hormone. We developed and validated a multivariate whole-blood mRNA-based predictor of melatonin phase which requires few samples. Transcriptome data were collected under normal, sleep-deprivation and abnormal sleep-timing conditions to assess robustness of the predictor. Partial least square regression (PLSR), applied to the transcriptome, identified a set of 100 biomarkers primarily related to glucocorticoid signaling and immune function. Validation showed that PLSR-based predictors outperform published blood-derived circadian phase predictors. When given one sample as input, the R2 of predicted vs observed phase was 0.74, whereas for two samples taken 12 hr apart, R2 was 0.90. This blood transcriptome-based model enables assessment of circadian phase from a few samples.https://elifesciences.org/articles/20214biomarkertranscriptomicsmachine learningsleep disordersneurodegenerationchronotherapy
spellingShingle Emma E Laing
Carla S Möller-Levet
Norman Poh
Nayantara Santhi
Simon N Archer
Derk-Jan Dijk
Blood transcriptome based biomarkers for human circadian phase
eLife
biomarker
transcriptomics
machine learning
sleep disorders
neurodegeneration
chronotherapy
title Blood transcriptome based biomarkers for human circadian phase
title_full Blood transcriptome based biomarkers for human circadian phase
title_fullStr Blood transcriptome based biomarkers for human circadian phase
title_full_unstemmed Blood transcriptome based biomarkers for human circadian phase
title_short Blood transcriptome based biomarkers for human circadian phase
title_sort blood transcriptome based biomarkers for human circadian phase
topic biomarker
transcriptomics
machine learning
sleep disorders
neurodegeneration
chronotherapy
url https://elifesciences.org/articles/20214
work_keys_str_mv AT emmaelaing bloodtranscriptomebasedbiomarkersforhumancircadianphase
AT carlasmollerlevet bloodtranscriptomebasedbiomarkersforhumancircadianphase
AT normanpoh bloodtranscriptomebasedbiomarkersforhumancircadianphase
AT nayantarasanthi bloodtranscriptomebasedbiomarkersforhumancircadianphase
AT simonnarcher bloodtranscriptomebasedbiomarkersforhumancircadianphase
AT derkjandijk bloodtranscriptomebasedbiomarkersforhumancircadianphase